Entity Details

Primary name CP2U1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ7Z449
EntryNameCP2U1_HUMAN
FullNameCytochrome P450 2U1
TaxID9606
Evidenceevidence at protein level
Length544
SequenceStatuscomplete
DateCreated2007-06-26
DateModified2021-06-02

Ontological Relatives

GenesCYP2U1

GO terms

Show/Hide Table
GOName
GO:0005506 iron ion binding
GO:0005737 cytoplasm
GO:0005743 mitochondrial inner membrane
GO:0005789 endoplasmic reticulum membrane
GO:0006082 organic acid metabolic process
GO:0006805 xenobiotic metabolic process
GO:0008395 steroid hydroxylase activity
GO:0016021 integral component of membrane
GO:0016712 oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
GO:0020037 heme binding
GO:0042738 exogenous drug catabolic process
GO:0043231 intracellular membrane-bounded organelle
GO:0052869 arachidonic acid omega-hydroxylase activity
GO:0097267 omega-hydroxylase P450 pathway
GO:0102033 long-chain fatty acid omega-hydroxylase activity

Subcellular Location

Show/Hide Table
Subcellular Location
Endoplasmic reticulum membrane
Microsome membrane
Mitochondrion inner membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001128 Cytochrome P450FamilyFamily
IPR002401 Cytochrome P450, E-class, group IFamilyFamily
IPR008069 Cytochrome P450, E-class, group I, CYP2D-likeFamilyFamily
IPR017972 Cytochrome P450, conserved siteSiteConserved site
IPR036396 Cytochrome P450 superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
615030 OMIMSpastic paraplegia 56, autosomal recessive (SPG56)A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. In SPG56, upper limbs are often also affected. Some SPG56 patients may have a subclinical axonal neuropathy. The disease is caused by variants affecting the gene represented in this entry.

Interactions

0 interactions

InteractorPartnerSourcesPublicationsLink